This study investigates the use of stereotactic body radiation and tumor treating fields in people with locally advanced pancreas cancer. The purpose is to evaluate if this combination can slow down the growth of the tumor.
The study evaluates the safety and effectiveness of using these treatments together. It focuses on how the treatments may impact tumor growth and any potential side effects.
- Who can participate: Adults with locally advanced pancreas cancer, confirmed by specific medical guidelines, may participate. They should have a good performance status and prior chemotherapy without disease progression.
- Study details: Participants will receive daily radiation therapy for five days and use a special system for at least 18 hours a day. This system is called a tumor treating field, and it works until the tumor progresses or severe side effects occur. A placebo is not involved in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand